TP53 and diabetes mellitus: As illustrated in Figure 6C, the comparison between the model group and the LDMY group revealed enrichment in several pathways, including the HIF-1 signaling pathway, p53 signaling pathway, Maturity Onset Diabetes of the Young, JAK-STAT signaling pathway, apoptosis, glycolysis/gluconeogenesis, RNA degradation, mTOR signaling pathway, Toll-like receptor signaling pathway, ferroptosis, FOXO signaling pathway, and NF-κB signaling pathway, among others.